Wednesday - December 10, 2025
A Routine Blood Test Could Help Predict Who Benefits Most From CAR T-Cell Therapy
December 08, 2025
PHILADELPHIA, Pennsylvania, Dec. 8 [Category: Health Care] -- The Fox Chase Cancer Center, a part of Temple University Health System, posted the following news:

* * *

A Routine Blood Test Could Help Predict Who Benefits Most From CAR T-Cell Therapy

*

* Measuring a patient's absolute lymphocyte count (ALC) can predict how well they'll respond to CAR T-cell therapy for non-Hodgkin lymphoma.

* How fast a patient's AL . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products